ArticlePloS one2016

Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.

Rehan Mujeeb Faridi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.